The combination of rosuvastatin and meloxicam enhances the radiotherapy efficacy of MCF7, T-47D, and MDA-MB-231 breast cancer cell lines.
Saved in:
| Title: | The combination of rosuvastatin and meloxicam enhances the radiotherapy efficacy of MCF7, T-47D, and MDA-MB-231 breast cancer cell lines. |
|---|---|
| Authors: | Naeimi, Arvin1 (AUTHOR), Saedi, Hamid Saeidi2 (AUTHOR), Bakhtiyari, Amir Mohsen1 (AUTHOR), Shabani, Kimia1 (AUTHOR), Babajani, Zahra1 (AUTHOR), Zahmatkesh, Mona Haddad3 (AUTHOR) haddad@gums.ac.ir |
| Source: | Research in Pharmaceutical Sciences. Jan/Feb2026, Vol. 21 Issue 1, p96-109. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!